Novo A/S
Latest statistics and disclosures from Novo Holdings A/S's latest quarterly 13F-HR filing:
- Top 5 stock holdings are VTI, BAM, BSX, ASML, CTLT, and represent 50.15% of Novo Holdings A/S's stock portfolio.
- Added to shares of these 10 stocks: ASML (+$144M), CTLT (+$141M), CRM (+$64M), ACLX (+$56M), TSM (+$48M), CRNX (+$9.3M), SILK (+$5.3M), NARI, LUNG, RLYB.
- Started 7 new stock positions in RLYB, CRNX, CTLT, ASML, TSM, ACLX, CRM.
- Reduced shares in these 10 stocks: EXAI (-$259M), VTI (-$93M), AAPL (-$54M), MORF (-$17M), Zogenix (-$7.2M), MIRM (-$5.4M), AERI, FRLN, ALGS, VECT.
- Sold out of its positions in AERI, EXAI, FRLN, Zogenix.
- Novo Holdings A/S was a net buyer of stock by $40M.
- Novo Holdings A/S has $1.9B in assets under management (AUM), dropping by -10.24%.
- Central Index Key (CIK): 0001388325
Tip: Access up to 7 years of quarterly data
Positions held by Novo A/S consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Novo Holdings A/S
Novo Holdings A/S holds 51 positions in its portfolio as reported in the March 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Vanguard Index Fds Total Stk Mkt (VTI) | 18.3 | $347M | -21% | 1.5M | 227.67 | |
| Brookfield Asset Mgmt Cl A Ltd Vt Sh (BAM) | 8.7 | $165M | 2.9M | 56.57 | ||
| Boston Scientific Corporation (BSX) | 8.1 | $153M | 3.5M | 44.29 | ||
| Asml Holding N V N Y Registry Shs (ASML) | 7.6 | $144M | NEW | 215k | 667.93 | |
| Catalent (CTLT) | 7.4 | $141M | NEW | 1.3M | 110.90 | |
| Apple (AAPL) | 5.6 | $107M | -33% | 611k | 174.61 | |
| Morphic Hldg (MORF) | 3.5 | $66M | -20% | 1.6M | 40.15 | |
| salesforce (CRM) | 3.3 | $64M | NEW | 299k | 212.32 | |
| Arcellx Common Stock (ACLX) | 3.0 | $56M | NEW | 4.0M | 14.02 | |
| Alibaba Group Hldg Sponsored Ads (BABA) | 2.9 | $55M | 501k | 108.80 | ||
| Edgewise Therapeutics (EWTX) | 2.9 | $54M | 5.6M | 9.70 | ||
| Mirum Pharmaceuticals (MIRM) | 2.6 | $48M | -10% | 2.2M | 22.02 | |
| Taiwan Semiconductor Mfg Sponsored Ads (TSM) | 2.5 | $48M | NEW | 459k | 104.26 | |
| Inogen (INGN) | 1.8 | $35M | 1.1M | 32.42 | ||
| Nkarta (NKTX) | 1.7 | $32M | 2.8M | 11.38 | ||
| Amicus Therapeutics (FOLD) | 1.3 | $24M | 2.6M | 9.47 | ||
| Cable One (CABO) | 1.2 | $23M | 16k | 1464.25 | ||
| Cyteir Therapeutics (CYT) | 1.0 | $18M | 4.8M | 3.77 | ||
| Io Biotech (IOBT) | 0.9 | $17M | 3.3M | 5.30 | ||
| Verve Therapeutics (VERV) | 0.9 | $17M | +7% | 750k | 22.82 | |
| Insmed Com Par $.01 (INSM) | 0.9 | $17M | 706k | 23.50 | ||
| Milestone Pharmaceuticals (MIST) | 0.9 | $16M | 2.5M | 6.42 | ||
| Vectivbio Hldg Ord Shs (VECT) | 0.8 | $16M | -4% | 3.4M | 4.71 | |
| Lava Therapeutics Nv SHS (LVTX) | 0.8 | $15M | 3.3M | 4.40 | ||
| Blueprint Medicines (BPMC) | 0.8 | $15M | +15% | 228k | 63.88 | |
| Iovance Biotherapeutics (IOVA) | 0.7 | $14M | 837k | 16.65 | ||
| Bolt Biotherapeutics (BOLT) | 0.7 | $12M | 4.5M | 2.74 | ||
| Silk Road Medical Inc Common (SILK) | 0.6 | $11M | +87% | 276k | 41.29 | |
| Inari Medical Ord (NARI) | 0.6 | $11M | +70% | 123k | 90.64 | |
| Inspire Med Sys (INSP) | 0.6 | $11M | +16% | 41k | 256.68 | |
| Seaspine Holdings (SPNE) | 0.6 | $10M | 859k | 12.16 | ||
| Pulmonx Corp (LUNG) | 0.5 | $10M | +66% | 410k | 24.81 | |
| Reneo Pharmaceuticals (RPHM) | 0.5 | $10M | 3.4M | 2.94 | ||
| Rocket Pharmaceuticals (RCKT) | 0.5 | $9.7M | 613k | 15.86 | ||
| Treace Med Concepts (TMCI) | 0.5 | $9.5M | 500k | 18.91 | ||
| Pharvaris N V (PHVS) | 0.5 | $9.4M | 516k | 18.14 | ||
| Crinetics Pharmaceuticals In (CRNX) | 0.5 | $9.3M | NEW | 425k | 21.95 | |
| Minerva Surgical (UTRS) | 0.5 | $9.2M | 2.0M | 4.50 | ||
| Spruce Biosciences (SPRB) | 0.5 | $9.1M | 4.5M | 2.01 | ||
| Kinnate Biopharma (KNTE) | 0.4 | $7.0M | +12% | 624k | 11.26 | |
| Checkmate Pharmaceuticals In | 0.4 | $6.9M | 2.2M | 3.19 | ||
| Galera Therapeutics (GRTX) | 0.3 | $5.9M | 2.5M | 2.38 | ||
| Galecto (GLTO) | 0.3 | $5.5M | 2.5M | 2.20 | ||
| Akouos (AKUS) | 0.3 | $5.0M | 1.1M | 4.75 | ||
| Marqeta Class A Com (MQ) | 0.3 | $4.9M | 442k | 11.04 | ||
| Aligos Therapeutics (ALGS) | 0.2 | $4.2M | -25% | 2.0M | 2.15 | |
| Alnylam Pharmaceuticals (ALNY) | 0.2 | $4.1M | 25k | 163.28 | ||
| Spero Therapeutics (SPRO) | 0.2 | $4.1M | 469k | 8.70 | ||
| Verona Pharma Sponsored Ads (VRNA) | 0.2 | $3.8M | 761k | 4.99 | ||
| Rallybio Corp (RLYB) | 0.2 | $3.0M | NEW | 436k | 6.98 | |
| Praxis Precision Medicines I (PRAX) | 0.1 | $2.6M | 250k | 10.21 |
Past Filings by Novo Holdings A/S
SEC 13F filings are viewable for Novo Holdings A/S going back to 2014
- Novo Holdings A/S 2022 Q1 restated filed May 27, 2022
- Novo Holdings A/S 2022 Q1 filed May 16, 2022
- Novo Holdings A/S 2021 Q4 filed Feb. 14, 2022
- Novo Holdings A/S 2021 Q3 filed Nov. 15, 2021
- Novo Holdings A/S 2021 Q2 filed Aug. 16, 2021
- Novo Holdings A/S 2021 Q1 filed May 17, 2021
- Novo Holdings A/S 2020 Q4 filed Feb. 16, 2021
- Novo Holdings A/S 2020 Q3 filed Nov. 16, 2020
- Novo Holdings A/S 2020 Q2 filed Aug. 14, 2020
- Novo Holdings A/S 2020 Q1 filed May 15, 2020
- Novo Holdings A/S 2019 Q4 filed Feb. 14, 2020
- Novo Holdings A/S 2019 Q3 filed Nov. 14, 2019
- Novo Holdings A/S 2019 Q2 filed Aug. 14, 2019
- Novo Holdings A/S 2019 Q1 filed May 15, 2019
- Novo Holdings A/S 2018 Q4 filed Feb. 14, 2019
- Novo Holdings A/S 2018 Q2 amended filed Feb. 6, 2019